Research Article

Bibliometric Analysis of Joint Publications on Human Papilloma Virus Vaccine and Cervical Cancer

Volume: 14 Number: 1 January 1, 2023
EN

Bibliometric Analysis of Joint Publications on Human Papilloma Virus Vaccine and Cervical Cancer

Abstract

Purpose: In this study, it is aimed to reveal the output, trends and important developments of researches globally by bibliometric analysis of joint publications on Human Papilloma Virus (HPV) vaccine and cervical cancer. Methods: It is a bibliometric visualized study using the Web of Science (WoS) database. A search query was made with keywords. As a result of the search, 158 out of 923 articles were excluded because they did not meet the specified criteria. 771 articles were analyzed. VOSviewer 1.6.12 was used to visualize bibliometric analyzes and network analysis was performed. Calculated values were presented as frequency (n) and percentage (%). Results: It was found that the most common publications on HPV vaccine and cervical cancer were in 2021 (n=94). In the countries with the highest number of research articles, the USA is in the first place with 281 research articles, followed by the UK and Australia. Our country, Turkey, had 16 publications in this field. The first magazine “Vaccine” and “PLOS one” published about 11% of its articles. The three most frequently used keywords were “cervical cancer”, “human papillomavirus” and “HPV”. Conclusion: In recent years, the number of studies focusing on HPV vaccine and cervical cancer has increased. It is seen that developed countries have done the most studies on the subject. To improve the global output of research in this area, it would be beneficial to establish strong research cooperation between developing and developed countries.

Keywords

References

  1. Reference1. Dağ H, Dönmez S, Sezer H, et al. The efects of two diferent teaching techniques on the knowledge level of nursing students about Hpv. Gaziantep Medical Journal. 2015; 21(2): 90–98.
  2. Reference2. Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;4:660-64.
  3. Reference3. Aydoğdu SGM and Özsoy Ü. Serviks Kanseri ve Hpv. Androl Bul. 2018;20: 25–29.
  4. Reference4. WHO- WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. WHO (2022). Cervical Cancer. [cited 2022 Oct 11]; Available from:https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
  5. Reference5. Serrano B, de Sanjosé S, Tous S, et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015;51(13):1732-41. doi: 10.1016/j.ejca.2015.06.001.
  6. Reference1. Sanjose S, Brotons M and Pavon MA. The Natural History of Human Papillomavirus Infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13. doi: 10.1016/j.bpobgyn.2017.08.015
  7. Reference7. WHO. Countries using hpv vaccine [Internet]. WHO. [cited 2022 Oct 10]; Available from: https://www.who.int/immunization/dis eases/hpv/decision_implementation/en/
  8. Reference8. World Health Organization (WHO). Human papillomavirus vaccines: WHO position paper, May 2017. Weekly Epidemiological Record. 2017;19(92): 241–268

Details

Primary Language

English

Subjects

Obstetrics and Gynaecology

Journal Section

Research Article

Publication Date

January 1, 2023

Submission Date

October 14, 2022

Acceptance Date

December 12, 2022

Published in Issue

Year 1970 Volume: 14 Number: 1

EndNote
Özdemir Ş, Şahin K (January 1, 2023) Bibliometric Analysis of Joint Publications on Human Papilloma Virus Vaccine and Cervical Cancer. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14 1 61–67.

Cited By